Patient Square Bets Big on NKTR: A Deep Dive for Investors
A prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
Understanding when to start thinking about retirement can make a big difference. Explore key factors to help you plan effectively.
24,441 articlesA prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
The SEC is moving to enable tokenized stocks on crypto platforms, potentially ushering in 24/7 on-chain trading and n...
A landmark federal lawsuit puts civil rights under a new spotlight as the Trump-appointed EEOC chair sues The New Yor...
As Hovnanian prepares to report Q2 2026 earnings, investors will scrutinize backlog, margins, and guidance. This anal...
When markets swing lower, the best blue chip stock often isn’t the flashiest name. This guide explains why a stalwart...
Natural gas equities are delivering higher yields than broad dividend ETFs as of 2026, driven by midstream cash flows...
NVIDIA stock struggled over the last week despite solid earnings. This guide breaks down the reasons behind the move ...
Sui faced back-to-back outages, pushing the token to a 20% weekly slide. This piece breaks down what happened, why it...
Bitcoin tumbled to the low $71,000s on June 1, 2026, as geopolitical tensions sparked a wave of liquidations across c...
Cathie Wood's Ark Invest has been quietly loading up on Nvidia this week. Here are three solid reasons why her buying...
As Anthropic prepares an IPO, history warns that sky-high private valuations rarely translate into smooth public-mark...
SPYI is delivering a near-12% yield year-to-date, but most distributions are classified as return of capital, which c...